Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | N542_E543del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK2 N542_E543del is an exon 12 deletion that results in the deletion of two amino acids of the Jak2 protein from amino acids 542 to 543 (PMID: 17267906). N542_E543del confers a gain of function to the Jak2 protein as demonstrated by increased proliferation, Jak2 phosphorylation, and downstream Stat5 phosphorylation (PMID: 17267906). |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 act mut JAK2 N542_E543del JAK2 mutant JAK2 exon12 JAK2 N542_E543del |
Transcript | NM_004972.4 |
gDNA | chr9:g.5070035_5070040delAATGAA |
cDNA | c.1624_1629delAATGAA |
Protein | p.N542_E543delNE |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322194.2 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322204.1 | chr9:g.5078384_5078389delAATCCT | c.1624_1629delAATCCT | p.N542_P543delNP | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322198.2 | chr9:g.5090523_5090528delCGGATA | c.1624_1629delCGGATA | p.R542_I543delRI | RefSeq | GRCh38/hg38 |
NM_001322199.2 | chr9:g.5090523_5090528delCGGATA | c.1624_1629delCGGATA | p.R542_I543delRI | RefSeq | GRCh38/hg38 |
NM_001322204 | chr9:g.5078384_5078389delAATCCT | c.1624_1629delAATCCT | p.N542_P543delNP | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322198.1 | chr9:g.5090523_5090528delCGGATA | c.1624_1629delCGGATA | p.R542_I543delRI | RefSeq | GRCh38/hg38 |
NM_001322199 | chr9:g.5090523_5090528delCGGATA | c.1624_1629delCGGATA | p.R542_I543delRI | RefSeq | GRCh38/hg38 |
NM_001322204.2 | chr9:g.5078384_5078389delAATCCT | c.1624_1629delAATCCT | p.N542_P543delNP | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
NM_001322198 | chr9:g.5090523_5090528delCGGATA | c.1624_1629delCGGATA | p.R542_I543delRI | RefSeq | GRCh38/hg38 |
NM_001322199.1 | chr9:g.5090523_5090528delCGGATA | c.1624_1629delCGGATA | p.R542_I543delRI | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5070035_5070040delAATGAA | c.1624_1629delAATGAA | p.N542_E543delNE | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK2 exon12 | polycythemia vera | not applicable | N/A | Guideline | Diagnostic | JAK2 exon 12 mutations aid in the diagnosis of polycythemia vera (NCCN.org). | detail... |
JAK2 mutant | B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | essential thrombocythemia | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of essential thrombocythemia (NCCN.org). | detail... |
JAK2 mutant | myelofibrosis | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of primary myelofibrosis (NCCN.org). | detail... |
JAK2 mutant | childhood B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in pediatric patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |